Surgical treatment and outcome of pulmonary hamartoma: a retrospective study of 10-year experience

  • Hıdır EsmeEmail author
  • Ferdane Melike Duran
  • Yasar Unlu
Original Article



The present retrospective study was designed to review the clinicopathological features and outcome of surgical treatment of pulmonary hamartoma who underwent surgical operation between January 2008 and January 2018.


The information about the age and gender of patients, symptoms, history of tobacco consumption, the presence of malignancies, radiological and imaging findings, calcification in the hamartoma, location and size of the lesions, findings of preoperative diagnostic investigations, operative procedures, operative time, tube drainage duration, surgical complication, hospital stay after tumor resection, duration of follow-up, and outcome were recorded.


The average size of the neoplasms was 2.72 cm. Five patients (20.8%) had malignancies, which occurred previously in two patients, and concomitantly in three patients. Twenty-four patients underwent surgical treatment which included enucleation in 14 (four cases had thoracoscopic surgery), wedge resection in 8 (six cases had thoracoscopic surgery), and lobectomy in 2 patients. A total of four postoperative complications were noted. The patients were followed up for 2–98 months.


Enucleation was the main choice in our series. The follow-up for a long period revealed no malignant transformation and recurrence. Due to lack of the malignance after operation in our series, we presumed that the enucleation for pulmonary hamartoma was safe enough.


Hamartoma Treatment Outcome 


Compliance with ethical standards

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Van den Bosch J, Wagenaar S, Corrin B, Elbers JR, Knaepen PJ, Westermann CJ. Mesenchymoma of the lung (so-called hamartoma): a review of 154 parenchymal and endobronchial cases. Thorax. 1987;42:790–3.Google Scholar
  2. 2.
    Gjevre JA, Myers JL, Prakash UB. Pulmonary hamartomas. Mayo Cline Proc. 1996;71:14–20.Google Scholar
  3. 3.
    Tomashefski JF Jr. Benign endobronchial mesenchymal tumors: their relationship to parenchymal pulmonary hamartomas. Am J Surg Pathol. 1982;6:531–40.CrossRefPubMedGoogle Scholar
  4. 4.
    Itoga M, Kobayashi Y, Takeda M, et al. A case of pulmonary hamartoma showing rapid growth. Case Rep Med. 2013;2013:231652.
  5. 5.
    Lu Z, Qian F, Chen S, Yu G. Pulmonary hamartoma resembling multiple metastases: a case report. Oncol Lett. 2014;7:1885–8.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Hansen CP, Holtveg H, Francis D, Rasch L, Bertelsen S. Pulmonary hamartoma. J Thorac Cardiovasc Surg. 1992;104:674–8.PubMedGoogle Scholar
  7. 7.
    Bateson EM. Relationship between intrapulmonary and endobronchial cartilage-containing tumors (so-called hamartoma). Thorax. 1965;20:447–61.CrossRefPubMedCentralGoogle Scholar
  8. 8.
    Bergh NP, Hafstrom LO, Scherson T. Hamartoma of the lung: with special reference to the endobronchial localization. Scand J Respir Dis. 1967;48:201–7.PubMedGoogle Scholar
  9. 9.
    Kang MW, Han JH, Yu JH, et al. Multiple central endobronchial chondroid hamartoma. Ann Thorac Surg. 2007;83:691–3.CrossRefPubMedGoogle Scholar
  10. 10.
    Minami Y, Iijima T, Yamamoto T, et al. Diffuse pulmonary hamartoma: a case report. Pathol Res Pract. 2005;200:813–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Ribet M, Jaillard-Thery S, Nuttens MC. Pulmonary hamartoma and malignancy. J Thorac Cardiovasc Surg. 1994;107:611–4.PubMedGoogle Scholar
  12. 12.
    Siegelman SS, Khouri NF, Scott WW Jr, et al. Pulmonary hamartoma: CT findings. Radiology. 1986;160:313–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Karasik A, Modan M, Jacob CO, Lieberman Y. Increased risk of lung cancer in patient with chondromatous hamartoma. J Thorac Cardiovasc Surg. 1980;80:217–20.PubMedGoogle Scholar
  14. 14.
    Guo W, Zhao YP, Jiang YG, Wang RW, Ma Z. Surgical treatment and outcome of pulmonary hamartoma: a retrospective study of 20-year experience. J Exp Clin Cancer Res. 2008;27:8.
  15. 15.
    Hamper UM, Khouri NF, Stitik FP, Siegelman SS. Pulmonary hamartoma: diagnosis by transthoracic needle-aspiration biopsy. Radiology. 1985;155:15–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Dunbar F, Leiman G. The aspiration cytology of pulmonary hamartomas. Diagn Cytopathol. 1989;5:174–80.CrossRefPubMedGoogle Scholar
  17. 17.
    Hummel P, Cangiarella JF, Cohen JM, Yang G, Waisman J, Chhieng DC. Transthoracic fine-needle aspiration biopsy of pulmonary spindle cell and mesenchymal lesions: a study of 61 cases. Cancer. 2001;93:187–98.CrossRefPubMedGoogle Scholar
  18. 18.
    Lien YC, Hsu HS, Li WY, et al. Pulmonary hamartoma. J Chin Med Assoc. 2004;67:21–6.PubMedGoogle Scholar

Copyright information

© Indian Association of Cardiovascular-Thoracic Surgeons 2018

Authors and Affiliations

  1. 1.Department of Thoracic Surgery, Konya Training and Research HospitalHealth Sciences UniversityKonyaTurkey
  2. 2.Department of Patholgy, Konya Training and Research HospitalHealth Sciences UniversityKonyaTurkey

Personalised recommendations